Estrogen Receptor Negative Breast Cancer in India: Do We Really Have Higher Burden of this Subtype?
ER negative and Triple negative breast cancers carry a poorer prognosis and are not amenable to hormone therapy. It has been previously observed that Indian patients with breast cancer have a higher tendency to have these tumours. Whether this is due to inherent biological differences in the tumours of our patients is a matter of much debate. We have analysed 250 patients of breast cancer for hormone receptor status, compared them with western series, and attempted to support the hypothesis that the higher ER negativity and triple negativity is indeed due to different tumour biology.
Suraj
S
Manjunath
Jyothi S
JS
Prabhu
Rohini
R
Kaluve
Marjorie
M
Correa
T S
TS
Sridhar